Skip to content

The Effects Of DBS Of Subthalamıc Nucleus On Functionality In Patıents With Parkinson's Disease: Short-Term Results

The Effects Of Deep Brain Stimulation Of Subthalamıc Nucleus On Pulmonary Function Tests and Functionality In Patıents With Parkinson's Disease: Short Term Results

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03797976
Enrollment
10
Registered
2019-01-09
Start date
2018-01-01
Completion date
2019-12-30
Last updated
2019-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Weakness, Parkinson Disease, Respiration; Decreased, Surgery

Brief summary

Parkinson's disease is a progressive chronic neurodegenerative disease. In cases where drug treatment is insufficient and drug use is not possible due to drug side effects, highly effective and low-risk surgical treatment options could be used. In Parkinson's Disease; findings such as chest wall rigidity and weakness of the respiratory muscle strength occur. The aim of this study was to determine the effect of preop and postop DBS surgery on respiratory muscle strength, respiratory function and physical performance in patients with Parkinson's disease.

Detailed description

In the study, at least 10 patients with Parkinson's disease who had DBS surgery in Mustafa Kemal University Research and Practice Hospital, Department of Brain and Nerve Surgery will be evaluated. Demographic-physical features, pulmonary functions, respiratory muscle strength, exercise capacity, functionality, and muscle strength will be evaluated

Interventions

DEVICEMIP and MEP

Pre-op, Post-op of, 1 month after surgery, 3 months after surgery

Sponsors

Mustafa Kemal University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Lack of any neurological disease other than Parkinson's * DBS surgery to be performed in the STN region

Exclusion criteria

* Patients with advanced cognitive impairment * Patients with pulmonary, neurological and orthopedic diseases affecting functionalities * Pregnancy * Patients in whom the stimulation was canceled due to infection after surgery.

Design outcomes

Primary

MeasureTime frameDescription
Functional exercise capacityChange from Baseline Functional exercise capacity at 3 months(Pre-op,Post-op Off, Post-op 1. month, Post-op 3. Month), an average of 3 months6 minute walking test

Secondary

MeasureTime frameDescription
Pulmonary functionsChange from Pulmonary functions at 3 months(Pre-op,Post-op Off, Post-op 1. month, Post-op 3. Month), an average of 3 monthsSpirometry
Inspiratory and expiratory muscle strength (MIP, MEP)Change from Inspiratory and expiratory muscle strength (MIP, MEP) at 3 months(Pre-op,Post-op Off, Post-op 1. month, Post-op 3. Month), an average of 3 monthsMouth pressure device
Muscle strengthChange from Peripheral muscle strength at 3 months(Pre-op,Post-op Off, Post-op 1. month, Post-op 3. Month), an average of 3 monthsMuscle Testing Device (N)
Grip Test (Peripheral muscle strength)Change from Peripheral muscle strength at 3 months(Pre-op,Post-op Off, Post-op 1. month, Post-op 3. Month), an average of 3 monthsHand Held Dynamometer (kgf)

Countries

Turkey (Türkiye)

Contacts

Primary ContactDeran Oskay, PhD
deranoskay@yahoo.com0312 2162600
Backup ContactBircan Yucekaya, MSc
bircanyucekaya@hotmail.com03262455516

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026